INNOVATION REVIEW: Closed, Open, Collaborative, Disruptive, Inclusive, Nested… and soon Reverse How about the Metrics: Dream and Reality

Innovation, a subject of massive interest:- is multiple and subject to overlapping descriptors: Closed, Open, Collaborative, Disruptive, Inclusive, Nested

[1]  M. Feldman,et al.  Entpreprenerial Universities and Technology Transfer: A Conceptual Framework for Understanding Knowledge-Based Economic Development , 2006 .

[2]  A. Salter,et al.  Open for innovation: the role of openness in explaining innovation performance among U.K. manufacturing firms , 2006 .

[3]  Clayton M. Christensen,et al.  Disruptive Technologies: Catching the Wave , 1995 .

[4]  Eric Mankin,et al.  Measuring innovation performance , 2007, Innovation for Sustainable Development Review – Belarus.

[5]  Heidi Ledford Universities struggle to make patents pay , 2013, Nature.

[6]  Louis J. Picker,et al.  HIV-1 Vaccines and Adaptive Trial Designs , 2011, Science Translational Medicine.

[7]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[8]  Vinit Nijhawan,et al.  MORE THAN MONEY: THE EXPONENTIAL IMPACT OF ACADEMIC TECHNOLOGY TRANSFER. , 2014, Technology and innovation.

[9]  Erwin Danneels Disruptive Technology Reconsidered: A Critique and Research Agenda , 2004 .

[10]  E. Thiel,et al.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. , 2009, The New England journal of medicine.

[11]  J. West,et al.  Open innovation : researching a new paradigm , 2008 .

[12]  A. Bouchie,et al.  Nature Biotechnology's academic spinouts of 2013 , 2014, Nature Biotechnology.

[13]  I. Cockburn,et al.  Public-Private Interaction and the Productivity of Pharmaceutical Research , 1997 .

[14]  Damien Lapray,et al.  "Bigger Data" Visualization to Visual Analytics: a path to Innovation. "Happening, definitely! Misleading, possibly?" A review of some examples applicable to IP Discovery , 2014 .

[15]  H. Chesbrough,et al.  A better way to innovate. , 2003, Harvard business review.

[16]  Damien Lapray,et al.  A Review assessing the "used in the art" Intellectual Property Search Methods and the Innovation Impact therewith , 2014 .

[17]  K I Kaitin,et al.  Deconstructing the Drug Development Process: The New Face of Innovation , 2010, Clinical pharmacology and therapeutics.

[18]  F. Narin,et al.  Direct validation of citation counts as indicators of industrially important patents , 1991 .

[19]  B. Munos Lessons from 60 years of pharmaceutical innovation , 2009, Nature Reviews Drug Discovery.

[20]  Diana P. Hoyt The Innovation Master Plan: The CEO's Guide to Innovation, Volume 2 , 2012 .

[21]  A. Trkola,et al.  HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Graham Warwick,et al.  Going for growth , 2010, Nature.

[23]  H. Etzkowitz Innovation in Innovation: The Triple Helix of University-Industry-Government Relations , 2002 .

[24]  Georges Haour,et al.  From Science to Business: How Firms Create Value by Partnering with Universities , 2010 .

[25]  G. Kleter,et al.  Genetically modified animals from life-science, socio-economic and ethical perspectives: examining issues in an EU policy context. , 2013, New biotechnology.

[26]  Clayton M. Christensen,et al.  The innovator's DNA. , 2009, Harvard business review.

[27]  David Saltmarsh,et al.  Seeking to teach equitably: Australian teacher education in a globalised world , 2013 .

[28]  Milton Narváez The Global Innovation Index 2012 , 2013 .

[29]  B. Kirkpatrick,et al.  Stem Cell Research and Therapy: The Position of the National Society of Genetic Counselors , 2013, Journal of Genetic Counseling.

[30]  J. Manyika,et al.  Disruptive technologies: Advances that will transform life, business, and the global economy , 2013 .

[31]  S. Anthony,et al.  Mapping your innovation strategy. , 2006, Harvard business review.